Release Date: 26/08/20 09:38 Summary: Positive Results from IHL-675A (ARDS) in vitro Study Price Sensitive: Yes Download Document 301.35KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%